Ketamine News and Research

RSS
General anesthesia can cause cognitive impairment in children

General anesthesia can cause cognitive impairment in children

New sensor can detect 'date rape' drugs

New sensor can detect 'date rape' drugs

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Fast-acting antidepressant effect of ketamine

Fast-acting antidepressant effect of ketamine

Multiple exposures to anesthesia may increase risk of ADHD, learning disabilities in young children

Multiple exposures to anesthesia may increase risk of ADHD, learning disabilities in young children

Evidence of damaged baby brains & inadequate anesthetic induced sleep: Conference updates

Evidence of damaged baby brains & inadequate anesthetic induced sleep: Conference updates

Naurex announces completion of $18 million Series A financing

Naurex announces completion of $18 million Series A financing

Comprehensive book on chronic pain and addiction

Comprehensive book on chronic pain and addiction

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

General anesthesia's similarities with and differences from sleep and coma

General anesthesia's similarities with and differences from sleep and coma

Ketamine tried on college students in experiments sparks outrage

Ketamine tried on college students in experiments sparks outrage

Naurex's antidepressant shares efficacy mechanisms with NMDA receptor antagonist ketamine

Naurex's antidepressant shares efficacy mechanisms with NMDA receptor antagonist ketamine

Study finds ketamine-propofol combination effective for pediatric procedural sedation

Study finds ketamine-propofol combination effective for pediatric procedural sedation

Emergency physicians to present research studies at Research Forum 2010

Emergency physicians to present research studies at Research Forum 2010

Study finds ketamine restores connection in chronic stress affected brain cells

Study finds ketamine restores connection in chronic stress affected brain cells

Ketamine reduces depression in treatment-resistant bipolar disorder: Study

Ketamine reduces depression in treatment-resistant bipolar disorder: Study

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

Arena Pharmaceuticals reports lower net loss allocable to common stockholders in fourth-quarter 2009

Arena Pharmaceuticals reports lower net loss allocable to common stockholders in fourth-quarter 2009

Scopolamine drug: A rapid-acting antidepressant for depression symptoms

Scopolamine drug: A rapid-acting antidepressant for depression symptoms

Third party reexamination of Phase III study of Ereska meets primary endpoint

Third party reexamination of Phase III study of Ereska meets primary endpoint